Key points are not available for this paper at this time.
This single-center retrospective study explores the safety and efficacy of 177 Lu-DOTATATE in children and young adult population with metastatic/inoperable neuroendocrine tumors (NETs).
Aggarwal et al. (Tue,) studied this question.